卖什么
Control lab instruments with natural language.
商业模式拆解
买家：谁掌握预算？
未核实Lab directors / heads of core facilities, diagnostic labs and production labs that run many protocols across different instruments (inferred from the FAQ on who they work with).
触发点：什么让他们现在购买？
Lab staff burn time turning ambiguous written protocols into machine code for liquid handlers and other instruments; knowledge sits in individual heads and leaves when people leave.
工作流：什么输入变成什么输出？
Describe the experiment or upload a methods document, Infera compiles it into validated instrument instructions (collision and volume checks), a human reviews the preview, then the run is exported to the instrument with an audit trail.
经济账：省了什么，怎么收费？
Tiered pricing by lab size and usage, from small academic lab to production facility; no numbers published for the lab-automation product. Companion BioBase desktop agent app is credit-based.
渠道：怎么接触到客户？
Pilot-led and founder-led: labs apply via an early-access form or book a 30-min call; Infera staff set up in the lab within a few weeks. Mostly Boston and Bay Area.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| — | YC 2026 春季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.